Jul 2026· Expert Review of Gastroenterology & Hepatology· Vol 20, pp. 721 - 732· 1 citation· 39 references
Medicine
TL;DR
The new diagnostic entities such as reflux hypersensitivity, reflux negative esophageal pain disorder, supragastric belching, functional pediatric feeding disorders, centrally mediated abdominal pain syndrome, biliary pain syndrome, proctalgia fugax, functional diarrhea, functional bloating, and infant distress syndrome were discussed in detail.
Abstract
ABSTRACT Introduction The Rome criteria have provided the acclaimed global standard for diagnosing pediatric functional gastrointestinal disorders. With the release of Rome criteria V in 2026, the field has undergone a major transformation. The notable changes are the replacement of the term functional gastrointestinal disorders with disorders of gut–brain interaction (DGBIs) and shifting from age-based subdivisions to an anatomical and symptom cluster framework. Area covered We reviewed pediatric Rome V documents and available evidence to cover both upper and lower gastrointestinal disorders of gut-brain interaction (DGBI). The new diagnostic entities such as reflux hypersensitivity, reflux negative esophageal pain disorder, supragastric belching, functional pediatric feeding disorders, centrally mediated abdominal pain syndrome, biliary pain syndrome, proctalgia fugax, functional diarrhea, functional bloating, and infant distress syndrome were discussed in detail. Expert opinion Rome V provides clinicians with a more precise diagnostic framework. However, many new entities remain descriptive, highlighting the urgent need for epidemiological studies, mechanistic research, and biomarker discovery. Large multicenter trials, in DGBI should be conducted using physiological studies, microbiome analysis, and psychosocial profiles to generate robust evidence on pathophysiology, and management strategies. Ultimately, Rome V should be seen as a launchpad for discovery–transforming descriptive categories into mechanically defined, therapeutically actionable disorders that improve outcomes for children worldwide.
For a long time, gastrointestinal disorders in children remained a "gray area" in clinical medicine, as the term "functional disorder" created the impression that the problem was of secondary importance. However, in recent years, it has become evident that this term conceals a complex, multi-component pathology affecti...
I. N. Zakharova, V. V. Pupykina, Y. Orobinskaya et al.· Pediatrics. Consilium Medicu...· 0 citations
Objective — to analyze current scientific data on the etiological and pathogenetic mechanisms underlying the development of functional dyspepsia in children, as well as the characteristics of its pharmacological and dietary management.
V. Bobrova, Y. Proshchenko· Modern Gastroenterology· 0 citations
BACKGROUND
22-30% of celiac disease (CD) patients on a strict gluten-free diet (GFD) experience persistent symptoms, defined as non-responsive CD (NRCD). Disorders of gut-brain interaction (DGBI), including irritable bowel syndrome (IBS) and functional dyspepsia, may contribute to persistent symptoms, but their prevale...
R. Rossi, B. Masoni, G. Migliorisi et al.· Clinics And Research in Hepa...· 0 citations
The evolving understanding of FD supports a shift from empirical symptom-based treatment toward individualized, mechanism-informed care, and emerging approaches targeting the duodenal microenvironment, epithelial barrier, gut microbiota, and gut–brain axis are promising.
H. Bednarz, Magdalena Mortka, Gabriela Piotrowska et al.· Quality in Sport· 0 citations
The Rome V Criteria, published in 2026, updates the scientific and clinical understanding of irritable bowel syndrome (IBS). It redefines IBS from a “functional disorder” to a “gut-brain interaction disorder,” emphasizing biological underpinnings. Recognized pathophysiological mechanisms include impaired motility, alte...
Tatiana B. Topchii, M. Ardatskaya, L. N. Maslovskii et al.· Consilium Medicum· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.